GILEAD SCIENCES NORWAY AS
Developing transformative medicines for life-threatening diseases globally.
Översikt
- 5
- Anställda
- 186.2milj NOK
- Omsättning
- 2007
- Grundat
Nyckelbeslutsfattare
Stacey Ma
Executive Vice President, Pharmaceutical Development and Manufacturing
Johanna Mercier
Chief Commercial & Corporate Affairs Officer
Keeley Cain Wettan
Executive Vice President & General Counsel, Legal and Compliance
Daniel O’Day
Chairman and Chief Executive Officer
+6 fler kontakter i Funnelfeedr
Beskrivning
Gilead Sciences is a research-based biopharmaceutical company dedicated to discovering, developing, and delivering innovative therapeutics for people with life-threatening diseases. The organization focuses its scientific rigor on three primary therapeutic areas: virology, oncology, and inflammation...